StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/307% below fair value
$27.40−2.96 (-9.75%)

Close on Nov 17, 2026Market cap $2.64BP/E –Yield –

IDEAYA Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

IDEAYA Biosciences's price to sales ratio was 13.5× on Nov 11, 2026, against 251.3× a year earlier. Over the last 4 years it ranged from 11.7× to 254.2×, with a median of 23.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202613.5×−235.3
2025Apr 30, 2025248.8×+69.7
2024Oct 31, 2024179.1×+90.3
2023Dec 29, 202388.8×+71.3
2022Dec 30, 202217.5×−8.1
2021Dec 31, 202125.6×–

More IDEAYA Biosciences figures

See a number that looks wrong?